Language selection

Search


Tradename information - 58301000087109

View tradename immunizing agents subset

Concept details

[RSVAb] BEYFORTUS 50 mg/0.5 mL


Pan-Canadian SNOMED CT terminology

Concept code
58301000087109
Concept status
active
Version
20240831
Display name
English: [RSVAb] BEYFORTUS 50 mg/0.5 mL
French: [RSVAc] BEYFORTUS 50 mg/0.5 mL
Abbreviation
English: RSVAb
French: RSVAc
Patient Picklist
English: BEYFORTUS
French: BEYFORTUS
Fully specified name
BEYFORTUS 50 milligrams per 0.5 milliliter solution for injection syringe Sanofi Vaccines Canada Ltd. (real clinical drug)
Market authorization holder
SANOFI VACCINES CANADA LTD.

Health Canada Drug Information

Drug Identification Number Product status Strength Typical dose External Links
02537206 Marketed See product monograph 0.5 ML

Linked product data

Lot numbers
  • not available

Linked concepts

Linked Immunization Route(s) of Administration

This vaccine protects against the following diseases:

This vaccine contains the following antigens:


National Vaccine Catalogue database details

Last updated
2026-03-12

Concept history

This concept replaces

Market Authorization Holder Concept History
Concept code Display name (en)
No data is available

Notice

Some information normally contained in the National Vaccine Catalogue may be unavailable due to ongoing mapping updates or because the source data did not provide the information, and in some cases, the information field is blank as it may not be applicable in the given context. The information contained in the National Vaccine Catalogue may also be subject to change following data reconciliation.

Disclaimer

The use of the standard SNOMED CT terminology and codes is subject to your annual acceptance of both the SNOMED CT® Affiliate License Agreement and the SNOMED CT® Canadian National License Agreement. To acknowledge and accept these agreements, register an account on Canada Health Infoway. For additional information on the agreements, please visit Canada Health Infoway.

Version:
1.6.0